Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00390481 · ClinicalTrials.gov registry record · NA
Study of Carotid Occlusion and Neurocognition
A NA study of Carotid Artery Diseases, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 294
- Enrollment target
- 1
- Study location
NCT00390481: Completed NA study of Carotid Artery Diseases, sponsored by Columbia University.
NCT00390481 is a NA study of Carotid Artery Diseases that has completed, run by Columbia University. The registered enrollment target is 294 participants, below the 1,626-participant average among 6 other Carotid Artery Diseases trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00390481, a NA study of Carotid Artery Diseases, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 294 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the relationship between cognitive functioning and blood flow in the brain among patients randomized to either extracranial-intracranial (EC-IC) bypass or medical therapy alone in the Carotid Occlusion Surgery Study (COSS).
Conditions Studied
Interventions
- PROCEDURE EC-IC Bypass in the COSS study
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 294 participants |
| Start Date | 2004-11 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT00390481 record still lists
NCT00390481 is an interventional study that assigns participants to a tested intervention. The registered 294 participants enrollment target is mid-sized for trials with a published cap, below the 1,626-participant average among 6 other Carotid Artery Diseases trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Carotid Artery Diseases appearing as the primary indexed condition, and to 1 intervention - of which EC-IC Bypass in the COSS study is the first listed.
NCT00390481 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00390481 about?
NCT00390481 is a clinical study titled "Study of Carotid Occlusion and Neurocognition". To determine the relationship between cognitive functioning and blood flow in the brain among patients randomized to either extracranial-intracranial (EC-IC) bypass or medical therapy alone in the Carotid Occlusion Surgery Study (COSS).
What is the current status of trial NCT00390481?
This trial is currently completed. It is a NA study. The enrollment target is 294 participants. The study started on 2004-11. Estimated completion is 2012-06.
What conditions does trial NCT00390481 study?
This clinical trial studies the following conditions: Carotid Artery Diseases.
What interventions are being tested in trial NCT00390481?
The interventions under investigation include: EC-IC Bypass in the COSS study (PROCEDURE).
Who is sponsoring clinical trial NCT00390481?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00390481 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Artery Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach
RECRUITING · NA
-
Assessing Neurocognition After Cerebrovascular Intervention
RECRUITING · NA
-
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
ACTIVE NOT RECRUITING · NA
-
Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)
COMPLETED · NA
-
The CREST-2 Registry
RECRUITING
-
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia